Andexanet Alfa for the Reversal of Factor Xa Inhibitor ActivityDeborah Siegal, Mark Crowther, John T. Curnutte et al.|New England Journal of Medicine|2015Cited by 1k
A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosisScott L. Friedman, Éric Lefebvre, Sven Francque et al.|Hepatology|2017Cited by 657
Recent Statistical Contributions to Medical Device DevelopmentBrian L. Wiens, Scott Berry, Ted Lystig|Therapeutic Innovation & Regulatory Science|2013Cited by 5